Disease Overview：Male Infertility（MI）
Male infertility is a clinical condition characterized by the inability of a male partner to achieve pregnancy with a fertile female partner after one year of regular, unprotected intercourse. It affects approximately 7% of men globally and may stem from diverse etiologies—including spermatogenic disorders (e.g., oligozoospermia, azoospermia), obstructive pathologies (e.g., congenital absence of the vas deferens), hormonal imbalances (e.g., hypogonadotropic hypogonadism), genetic abnormalities (e.g., Klinefelter syndrome, Y-chromosome microdeletions), or lifestyle-related factors such as varicocele, oxidative stress, or environmental toxin exposure. Diagnosis typically involves comprehensive semen analysis, hormonal profiling (FSH, LH, testosterone, prolactin), scrotal ultrasound, and, when indicated, genetic testing or testicular biopsy. Management ranges from medical therapy (e.g., clomiphene citrate, antioxidant regimens) and surgical interventions (e.g., microsurgical varicocelectomy, TESE/micro-TESE for sperm retrieval) to assisted reproductive technologies (ART), including ICSI.
China offers distinct advantages in male infertility care: its leading urology-and-andrology centers—many affiliated with top-tier academic hospitals—employ internationally trained specialists with extensive experience in complex cases, including non-obstructive azoospermia and post-chemotherapy fertility restoration. Advanced infrastructure includes next-generation semen analysis systems, high-magnification microsurgery suites, and integrated ART laboratories accredited by ISO and CAP standards. Clinical outcomes align with global benchmarks: micro-TESE success rates exceed 50% in select centers, and live birth rates per ICSI cycle reach 45–52% for male-factor infertility. Crucially, treatment costs in China are typically 40–60% lower than in the US, UK, or Germany—without compromising evidence-based protocols or safety standards.
As a dedicated medical tourism agency, we facilitate seamless international patient journeys: pre-arrival consultation, verified hospital referrals, transparent itemized pricing (covering diagnostics, procedures, medications, and follow-up), visa support, multilingual coordination, and post-treatment telehealth continuity—all designed to reduce uncertainty and optimize clinical and financial outcomes.
Male Infertility: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Male Infertility (Andrology Department)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Hormonal imbalances (hypogonadotropic hypogonadism), mild oligozoicocele-related subfertility without surgical indication, idiopathic infertility with normal anatomy.
- •HCG/hMG or Clomiphene)
- Monthly injectables (hCG 1,000 IU + hMG 75 IU × 2/wk): $180–$240/month citrate (25 mg/day): $15–$25/month - Semen analysis (post-treatment, 3-month interval): $30–$40/test
- •Antioxidant & Adjunctive Supplements
- Mandatory pre-supplement semen analysis + sperm DNA fragmentation test: $110–$140
Surgical / Procedural Options
*Eligibility criteria:* Clinical varicocele (Grade II–III), obstructive azoospermia (e.g., post-vasectomy, CBAVD), testicular failure workup requiring biopsy.
- •Microsurgical Varicocelectomy (bilateral, inguinal approach)
- Surgery fee (including OR time, microscope use, anesthesia): $1,450–$1,950 - Post-op semen analysis at 3/6 months: $30–$40/test
- •Percutaneous Sperm Retrieval (TESA/PESA)
- Procedure (under local anesthesia, unilateral/bilateral): $480–$650
- •Micro-TESE (Microdissection Testicular Sperm Extraction)
- Procedure (3–4 hr OR, intraoperative microscopy, tissue processing): $2,100–$2,750
Special / Complex Condition Management
- •Genetic Causes (Klinefelter, Y-deletion, CFTR mutations)
- IVF-ICSI coordination (sperm retrieval + embryology support): $4,200–$5,600 (separate from ART center fees)
- •Post-Chemotherapy/Radiation Recovery
- Gonadotropin stimulation trial (if residual spermatogenesis): $180–$240/month × 6 months
Quick Selection Guide
- •<35 years, mild oligozoospermia, budget < $500: Start with hormonal therapy + antioxidants ($220–$350 initial month)
- •35–42 years, palpable varicocele, moderate teratozoospermia: Microsurgical varicocelectomy ($1,580–$2,110 total first-year cost)
- •Azoospermia, normal FSH/testosterone: Proceed directly to micro-TESE ($2,420–$3,160, includes genetics & procedure)
- •Comorbid obesity/diabetes: Prioritize metabolic optimization (lifestyle + metformin) + semen analysis every 6 months ($75–$110/year) before escalating intervention
- •Severe male factor + female partner >38 years: Expedite micro-TESE + IVF-ICSI referral ($6,500–$8,750 total andrology + embryology coordination)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Male Infertility Medical Vacation Packages
Curated transparent all-inclusive packages combining Male Infertility treatment with China top medical destinations:
